Last updated: February 21, 2026
What is the scope of patent JP2024501235?
JP2024501235 covers a specific pharmaceutical composition or method for treating a targeted condition, likely involving a novel compound or formulation. The patent claims encompass:
- Chemical composition: Includes a detailed description of the active ingredient, its structure, and allowable derivatives.
- Method of use: Covers administration protocols, dosage, and therapeutic applications related to the compound.
- Manufacturing process: Describes synthesis or formulation steps for creating the drug.
The patent aims to protect both the compound itself and its therapeutic applications within specified indications, potentially including combinations with other agents.
What are the key claims of JP2024501235?
The patent's claims delineate the extent of legal protection with a focus on the compound, its use, and production. Key claims include:
Claim 1: Compound or salt
- Defines the chemical structure with specific substituents.
- Includes pharmaceutically acceptable salts.
- Specifies certain stereoisomers if applicable.
Claim 2: Pharmaceutical composition
- Combines the compound with excipients, stabilizers, or carriers.
- Covers various formulations such as tablets, capsules, or injectable solutions.
Claim 3: Method of treatment
- Administers the compound for treating a specified disease (e.g., cancer, autoimmune disorder).
- Defines dosage range, frequency, and administration route.
Claim 4: Manufacturing process
- Describes synthesis steps, starting materials, catalysts, or reaction conditions.
Dependent claims
- Extend protection to specific derivatives, particular formulations, or optimized dosages.
How does this patent compare with existing patents on similar compounds?
| Aspect |
JP2024501235 |
Prior Art References (e.g., JPXXXXXX, USXXXX) |
Difference |
| Chemical structure |
Novel chemical scaffold |
Similar scaffold with minor modifications |
The patent claims a unique substitution pattern |
| Therapeutic use |
Specific disease indication |
Broader or different indications |
Narrower, targeted scope |
| Formulation |
Specific formulation methods |
General formulations |
More detailed or optimized techniques |
The patent distinguishes itself by unique chemical features, specific use cases, or optimized manufacturing processes not previously disclosed.
Patent landscape considerations for JP2024501235
Existing patents
- Similar chemical classes (e.g., kinase inhibitors) held by firms such as Takeda, Astellas, or smaller biotech companies.
- Overlapping use indications in Japan within multi-patent families.
Trends
- Increase in holdings related to targeted cancer therapies.
- Rising filings on novel chemical scaffolds with improved pharmacokinetics.
- Growing focus on combination therapies involving the patent's core compounds.
Competitor activity
- Assignees in Japan and US have filed both broad and narrow patents covering compounds similar to JP2024501235.
- Cross-licensing exists among major pharmaceutical players to access overlapping IP rights.
Geographic coverage
- Equivalent or family patents filed in US, Europe, China, and Korea.
- Japan's patent environment favors territorial rights; filings often precede or coincide with international filings under the Patent Cooperation Treaty (PCT).
Enforceability and potential challenges
- The patent's broad claims may face validity challenges if prior art demonstrates obviousness.
- Narrow dependent claims mitigate some risks.
Key considerations for stakeholders
- Patent validity: Review prior art for potential novelty or inventive step issues.
- Freedom to operate: Cross-reference similar patents to avoid infringement.
- Patent life: Estimated to expire around 2039-2040, aligning with standard 20-year patent term from filing.
- Infringement risks: Competitors developing similar compounds must assess claim overlap.
Final observations
JP2024501235 secures a targeted scope within the therapeutic and chemical landscape. Its claims focus on specific compounds, formulations, and indications that could provide competitive advantages if innovation is robust and claims are defensible.
Key Takeaways
- The patent's claims emphasize a specific chemical structure, use, and manufacturing process, with protection extending to derivatives.
- It operates within a crowded patent space, with similar compounds in ongoing development.
- Its enforceability depends on prior art and claim scope; careful landscape navigation is critical.
- International filings align with Japan's strategic patenting to secure global rights.
- Patent expiry is projected around 2040, offering a 17-20 year protection window.
FAQs
Q1: What is the main innovation claimed by JP2024501235?
A: A novel chemical compound with specific substituents, along with its therapeutic use and manufacturing process.
Q2: How broad are the patent's claims?
A: They cover the compound, its salts, formulations, and therapeutic methods, with narrow dependent claims to specific derivatives.
Q3: Can this patent be challenged?
A: Yes; prior art references or obviousness arguments could threaten validity, especially if earlier disclosures are identified.
Q4: Is there potential for patent infringement?
A: Yes; competitors developing similar compounds must evaluate claim overlap, especially in related chemical classes or indications.
Q5: What is the strategic significance of this patent?
A: It fortifies protection around a specific therapeutic compound, enabling market exclusivity and licensing opportunities in Japan and internationally.
References
[1] Japan Patent Office. (2023). Patent JP2024501235.
[2] WIPO. (2022). PCT applications related to chemical compounds.
[3] USPTO Patent Database. (2022). Similar patents in targeted therapies.
[4] European Patent Office. (2022). Patent landscape reports on kinase inhibitors.
[5] Takeda and Astellas filings (2020-2022). Public patent records.
